Home   |  Kontaktandmed   |  Asukohad
Safe Infusion Therapy (ET)
 

Kirjandus


[1] Craven DH, Hirnle CJ (2007) Fundamentals of nursing – human death and function. 5th Edition, Philadelphia: Lippincott Williams & Wilkins 29: 566


[2] Cousins DH, Sabatier B, Begue D, Schmitt C, Hoppe-Tichy T (2005) Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France. QSHC 14: 190-195  www.ncbi.nlm.nih.gov/pubmed/15933316


[3] Douglas JB, Hedrick C (2001) Pharmacology Infusion therapy in clinical practice. Philadelphia: Saunders 176-208


[4] Friedman AL, Geoghegan SR et al. (2007) Medication errors in the outpatient setting: classification and root cause analysis. Arch Surg 142(3):278-83; discussion 284.
www.ncbi.nlm.nih.gov/pubmed/17372053


[5] Williams DJP (2007) Medication errors. J R Coll Physicians Edinb 37: 343-346 http://www.rcpe.ac.uk/journal/issue/journal_37_4/Williams.pdf


[6] Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS (2001) Medication administration errors in adult patients in the ICU. Intensive Care Med 27: 1592-1598
www.ncbi.nlm.nih.gov/pubmed?term=11685299


[7] Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E et al. (2005) The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 33: 1694-1700
www.ncbi.nlm.nih.gov/pubmed?term=16096443


[8] Valentin A, Capuzzo M, Guidet B, Moreno RP, Dolanski L, Bauer P et al. (2006) Patient safety in intensive care: results from the multinational Sentinel Events Evaluation (SEE) study. Intensive Care Med 32: 1591-1598
www.ncbi.nlm.nih.gov/pubmed?term=16874492%20


[9] Garrouste-Orgeas M, Timsit JF, Vesin A, Schwebel C, Arnodo P, Lefrant JY et al. (2010) Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II. Am J Respir Crit Care Med 181: 134-142
www.ncbi.nlm.nih.gov/pubmed?term=19875690%20


[10] Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B, Bauer P et al. (2009) Errors in administration of parenteral drugs in intensive care units: multinational prospective study. BMJ 338:b814. doi:10.1136/bmj.b814
www.ncbi.nlm.nih.gov/pubmed/19282436 


[11] Institute of Medicine (2007) Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academy Press; p. 111


[12] Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356: 1255-9
www.ncbi.nlm.nih.gov/pubmed/11072960


[13] Nebeker JR, Barach P, Samore MH (2004) Clarifying Adverse Drug Events: A Clinician´s Guide to terminology, Documentation, and Reporting. Ann Intern Med 140: 795-801 www.ncbi.nlm.nih.gov/pubmed/15148066


[14] Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA, 274: 29-34
www.ncbi.nlm.nih.gov/pubmed/7791255


[15] Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. (2000) Incidence and preventability of adverse drug events in nursing homes. Am J Me 109: 87-94
www.ncbi.nlm.nih.gov/pubmed?term=10967148%20


[16] Tissot E, Cornette C, Demoly P, Jacquet M, Barale F, Capellier G (1999) Medication errors at the administration stage in an intensive care unit. Intensive Care Med 25: 353-359
http://www.ncbi.nlm.nih.gov/pubmed?term=Tissot%20E%2C%20Cornette%20C%2C%20Demoly%20P%2C%20Jacquet%20M%2C%20Barale%20F%2C%20Capellier%20G%20(1999)%20Medication%20errors%20at%20the%20administration%20stage%20in%20an%20intensive%20care%20unit.%20Intensive%20Care%20Med%2025%3A%20353-359


[17] Fraind DB, Slagle JM, Tubbesing VA, Hughes SA, Weinger MB (2002) Reengineering intravenous drug and fluid administration processes in the operating room: step one: task analysis of existing processes. Anesthesiology 97: 139-147
www.ncbi.nlm.nih.gov/pubmed?term=12131115


[18] Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Ardakani MT (2008) Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Aust Crit Care 2: 110-116
www.ncbi.nlm.nih.gov/pubmed?term=18387813


[19] Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA (2001) Random and systematic medication errors in routine clinical practice: a multicenter study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol 52: 573-577
www.ncbi.nlm.nih.gov/pubmed?term=11736866


[20] Garnerin P, Pellet-Meier B, Chopard P, Perneger T, Bonnabry P (2007) Measuring human-error probabilities in drug preparation: a pilot simulation study. Eur J Clin Pharmacol 63: 769-776
www.ncbi.nlm.nih.gov/pubmed?term=17541570


[21] Parshuram CS, To T, Seto W, Trope A, Koren G, Laupacis A (2008) Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ 178: 42-48
www.ncbi.nlm.nih.gov/pubmed?term=18166730%20


[22] Cousins DH, Sabatier B, Begue D, Schmitt C, Hoppe-Tichy T (2005) Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France. QSHC 14: 190-195
www.ncbi.nlm.nih.gov/pubmed/15933316


[23] Cohen H, Robins ES, Mandrack M (2003) Getting to the root of medication errors: survey results. Nursing 33(9): 36-45
www.ncbi.nlm.nih.gov/pubmed/14501514


[24] Wilson RMcL, Harrison BT, Gibberd RW, Hamilton JD (1999) An analysis of the causes of adverse events from the Quality in Australian Health Care Study. Med J Aust 170: 411-415
www.ncbi.nlm.nih.gov/pubmed/10341771


[25] Leape LL, Bates DW, Cullen DJ, et al. (1995) Systems analysis of adverse drug events. JAMA 274: 35–43
www.ncbi.nlm.nih.gov/pubmed?term=7791256%20


[26] Vincent C, Taylor-Adams S, Chapman EJ, et al. (2000) How to investigate and analyse clinical incidents: Clinical Risk Unit and Association of Litigation and Risk Management protocol. BMJ 320: 777–81
www.ncbi.nlm.nih.gov/pubmed/10720366


[27] Reason J (2001) Understanding adverse events: the human factor. In: Vincent C, ed. Clinical risk management. London: BMJ Books 9–30 http://www.ncbi.nlm.nih.gov/pubmed/10151618


[28] Dean B, Schaechter M, Vincent C, et al. (2002) Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 359: 1373–8
www.ncbi.nlm.nih.gov/pubmed/11978334


[29] Stanhope N, Vincent C, Taylor-Adams S, et al. (1997) Applying human factors methods to clinical risk management in obstetrics. Br J Obstet Gynaecol 104: 1225–32
www.ncbi.nlm.nih.gov/pubmed?term=9386021


[30] Thur MP, Miller WA, Latiolais CJ (1972) Medication errors in a nurse controlled parenteral admixture programm. Am J Hosp Pharm 29: 298-304
www.ncbi.nlm.nih.gov/pubmed/5025259


[31] National Patient Safety Agency (2007) Patient Safety Alert:Promoting safer use of injectable medicines 20. Available from
http://www.nrls.npsa.nhs.uk/EasySiteWeb/getresource.axd?AssetID=60098&type=full&servicetype=Attachment

[32] Vincent C (2010) Patient safety. 2nd edition, Wiley Blackwell BMJ Books, p. 57


[33] Vincent C, Neale G, Woloshynowych M (2001) Adverse events in British hospitals: preliminary retrospective record review.BMJ 322: 517–9
www.ncbi.nlm.nih.gov/pubmed?term=11230064


[34] Kohn L, Corrigan J, Donaldson M (2000) To Err Is Human: Building a Safer Health System. Washington, DC: Committee on Quality of Health Care in America, Institute of Medicine. National Academies Press, ISBN: 9780309068376


[35] Ehsani J, Jackson T, Duckett S (2006) The incidence and cost of adverse events in Victorian hospitals 2003-2004. Med J Aust 184(11): 551-55
www.ncbi.nlm.nih.gov/pubmed/16768660


[36] Taxis K, Barber N (2003) Ethnographic study of incidence and severity of intravenous drug errors. BMJ 326: 684-688
www.ncbi.nlm.nih.gov/pubmed/12663404


[37] Dehmel C, Braune S, Kreymann G, Baehr M, Langebrake C, Hilgarth H, Nierhaus A, Dartsch D, Kluge S (2011) Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward? Intensive Care Med 2010-00231. R3 in press http://www.uke.de/zentrale-dienste/apotheke/downloads/gb-betriebe-apotheke/Dehmel_Intensive_Care_Med_2011.pdf


[38] Tissot E, Cornette C, Limat S, Mourand J, Becker M, Etievent J et al. (2003) Observational study of potential risk factors of medication administration errors. J Qual Improve 25(6): 264-68 http://www.ncbi.nlm.nih.gov/pubmed/14689814


[39] Vogel Kahmann I, Bürki R et al. (2003) Incompatibility reactions in the intensive care unit. Five years after the implementation of a simple “color code system”. Anaesthesist 52(5): 409-12 http://www.ncbi.nlm.nih.gov/pubmed/12750824


[40] Trissel LA (2011) Handbook on Injectable Drugs. 16th ed. Bethesda: American Society of Pharmacist


[41] Taxis K (2005) Who is responsible for the safety of infusion devices? It´s high time for action! Qual Saf Health Care 14(2): 76
www.ncbi.nlm.nih.gov/pubmed/15805448


[42] Rothschild JM, Keohane CA, Thompson S, Bates DW (2003) Intelligent Intravenous Infusion Pumps to improve Medication Administration Safety. AMIA Symposium Proceedings, p. 992
www.ncbi.nlm.nih.gov/pubmed/14728495


[43] Scroggs J (2008) improving patient safety using clinical needs assessments in IV therapy. Brit J Nurse (IV Therapy Suppl) 17(19): 22-28
www.ncbi.nlm.nih.gov/pubmed/18974682


[44] Briggs J (2006) Strategies to reduce medication errors with reference to older adults. Nurs Stand. 20(41):53-7.
www.ncbi.nlm.nih.gov/pubmed/16827204


[45] Etchells E, Juurlink D, Levinson W (2008) Medication errors: the human factor. CMAJ 178 (1): 63
www.ncbi.nlm.nih.gov/pubmed?term=18166734


[46] Langebrake C, Hilgarth H (2010) Clinical pharmacists´ interventions in a German University Hospital. Pharm World Sci 32(2): 194-99
www.ncbi.nlm.nih.gov/pubmed/20084548


[47] Kane-Gill SL, Jacobi J, Rothschild JM (2010) Adverse drug events in intensive care units: Risk factors, impact and the role of team care. Crit Care Med 38(6): 83-89
www.ncbi.nlm.nih.gov/pubmed/20502179


[48] Jones JH, Treiber L (2010) When 5 Rights Go Wrong. J Nurs Care Qual 25: 240-247
www.ncbi.nlm.nih.gov/pubmed?term=20164807

Sellel hüperlingil klõpsates lahkute meie veebilehelt. B. Braun ei ole avatava veebilehe omanik ega halda selle sisu.

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Product images are for reference only. Please contact your country representative for product availability and information.